Funding Received
$26.5 Million in 2 Rounds from 2 Investors
Most Recent Funding
$14 Million Series C on June 26, 2014
Founded:
2002
Headquarters:
Caesarea
Description:
Dune Medical Devices is engaged in the development and commercialization of intraoperative, real-time, cancer detection devices.
Founders:
Dan Hashimshony
Categories:
Health Care
Website:
http://www.dunemedical.com

Detailed Description

Update

Dune Medical Devices was founded in 2002 to realize the extraordinary medical potential of its proprietary tissue characterization technology. Offering surgeons and radiologists the ability to detect cancer in real time, this technology holds promise for a broad range of diagnostic and therapeutic applications. Surgeons who fight cancer on a daily basis must always contend with the lingering question, “Did I get it all?” It forces those who tackle breast cancer to consistently balance the imperative towards aggressive treatment with the desire to conserve tissue. A critical leveler in that struggle may be MarginProbe™ from Dune Medical. The MarginProbe™ System delivers real-time cancer detection in the OR for a simple and immediate assessment of cancer on the margin of excised tissue. In a randomized study of 300 breast cancer patients in Israel, the reoperation rate was reduced by 56% vs. standard of care when the MarginProbe System was employed.

Current Team (6)

Update

Past Team (3)

Update

Funding Rounds (2) - $26.5M

Update

Board Members and Advisors (3)

Update

Investors (2)

Update

Offices/Locations (1)

Update
  • Headquarters

    20 Alon Hatavor St., 38900

    Caesarea, 38900

    ISR

Images (1)

Update
  • Bb946ee6bf9e1e8b1f3d7c3fd7b46a8b

Portions of this content provided by: